TW200503678A - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: TW200503678A
Authority: TW; Taiwan
Prior art keywords: therapeutic agents; oxoethoxy; phenylethyl; ethoxy; hexyl
Prior art date: 2003-06-18

Application number

TW093116599A

Other languages

English (en)

Inventor

Ralf Ragnar

Erica Stahle

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-18

Filing date

2004-06-09

Publication date

2005-02-01

2004-06-09 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-02-01 Publication of TW200503678A publication Critical patent/TW200503678A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Psychology (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW093116599A 2003-06-18 2004-06-09 Therapeutic agents TW200503678A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0314136.3A GB0314136D0 (en)	2003-06-18	2003-06-18	Therapeutic agents

Publications (1)

Publication Number	Publication Date
TW200503678A true TW200503678A (en)	2005-02-01

Family

ID=27636795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093116599A TW200503678A (en)	2003-06-18	2004-06-09	Therapeutic agents

Country Status (21)

Country	Link
US (1)	US20060194879A1 (zh)
EP (1)	EP1638921A1 (zh)
JP (1)	JP3836498B1 (zh)
KR (1)	KR20060017646A (zh)
CN (1)	CN1805922A (zh)
AR (1)	AR044802A1 (zh)
AU (1)	AU2004247611A1 (zh)
BR (1)	BRPI0411455A (zh)
CA (1)	CA2527608A1 (zh)
CO (1)	CO5650229A2 (zh)
GB (1)	GB0314136D0 (zh)
IL (1)	IL172168A0 (zh)
IS (1)	IS8232A (zh)
MX (1)	MXPA05013713A (zh)
NO (1)	NO20055923L (zh)
RU (1)	RU2005138369A (zh)
SA (1)	SA04250170B1 (zh)
TW (1)	TW200503678A (zh)
UY (1)	UY28371A1 (zh)
WO (1)	WO2004110985A1 (zh)
ZA (1)	ZA200510199B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0104333D0 (sv)	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
GB0314079D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
GB0229931D0 (en) *	2002-12-21	2003-01-29	Astrazeneca Ab	Therapeutic agents
CN1319938C (zh)	2002-06-20	2007-06-06	阿斯特拉曾尼卡有限公司	治疗胰岛素抵抗的邻位取代的苯甲酸衍生物
WO2007004957A1 (en) *	2005-07-05	2007-01-11	Astrazeneca Ab	Novel crystalline form
AR055073A1 (es) *	2005-07-11	2007-08-01	Astrazeneca Ab	Agentes terapeuticos
FR2903985B1 (fr)	2006-07-24	2008-09-05	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2904316B1 (fr)	2006-07-31	2008-09-05	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
UY30648A1 (es) *	2006-10-20	2008-05-02	Janssen Pharmaceutica Nv	Formas salinas de compuestos de benzotienilo sustituido

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20020060067A (ko) *	1999-04-06	2002-07-16	가와무라 요시부미	α-치환 카르복실산 유도체
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents

2003
- 2003-06-18 GB GBGB0314136.3A patent/GB0314136D0/en not_active Ceased
2004
- 2004-06-09 TW TW093116599A patent/TW200503678A/zh unknown
- 2004-06-16 AU AU2004247611A patent/AU2004247611A1/en not_active Abandoned
- 2004-06-16 JP JP2006517040A patent/JP3836498B1/ja not_active Expired - Fee Related
- 2004-06-16 SA SA04250170A patent/SA04250170B1/ar unknown
- 2004-06-16 CA CA002527608A patent/CA2527608A1/en not_active Abandoned
- 2004-06-16 KR KR1020057024066A patent/KR20060017646A/ko not_active Withdrawn
- 2004-06-16 EP EP04736956A patent/EP1638921A1/en not_active Withdrawn
- 2004-06-16 CN CNA2004800168384A patent/CN1805922A/zh active Pending
- 2004-06-16 RU RU2005138369/04A patent/RU2005138369A/ru not_active Application Discontinuation
- 2004-06-16 US US10/560,127 patent/US20060194879A1/en not_active Abandoned
- 2004-06-16 WO PCT/SE2004/000965 patent/WO2004110985A1/en not_active Ceased
- 2004-06-16 MX MXPA05013713A patent/MXPA05013713A/es not_active Application Discontinuation
- 2004-06-16 BR BRPI0411455-8A patent/BRPI0411455A/pt not_active IP Right Cessation
- 2004-06-17 UY UY28371A patent/UY28371A1/es not_active Application Discontinuation
- 2004-06-17 AR ARP040102112A patent/AR044802A1/es not_active Application Discontinuation
2005
- 2005-11-24 IL IL172168A patent/IL172168A0/en unknown
- 2005-12-13 NO NO20055923A patent/NO20055923L/no not_active Application Discontinuation
- 2005-12-14 ZA ZA200510199A patent/ZA200510199B/en unknown
- 2005-12-28 CO CO05130776A patent/CO5650229A2/es unknown
2006
- 2006-01-13 IS IS8232A patent/IS8232A/is unknown

Also Published As

Publication number	Publication date
RU2005138369A (ru)	2007-07-27
CA2527608A1 (en)	2004-12-23
EP1638921A1 (en)	2006-03-29
UY28371A1 (es)	2005-01-31
IS8232A (is)	2006-01-13
SA04250170B1 (ar)	2007-10-29
AR044802A1 (es)	2005-10-05
IL172168A0 (en)	2009-02-11
ZA200510199B (en)	2006-12-27
CN1805922A (zh)	2006-07-19
JP3836498B1 (ja)	2006-10-25
CO5650229A2 (es)	2006-06-30
MXPA05013713A (es)	2006-06-27
NO20055923L (no)	2006-01-06
KR20060017646A (ko)	2006-02-24
US20060194879A1 (en)	2006-08-31
BRPI0411455A (pt)	2006-07-18
JP2006527767A (ja)	2006-12-07
AU2004247611A1 (en)	2004-12-23
WO2004110985A1 (en)	2004-12-23
GB0314136D0 (en)	2003-07-23

Publication	Publication Date	Title
TW200503678A (en)	2005-02-01	Therapeutic agents
CY1124753T1 (el)	2022-07-22	Συνθεση ενωσεων βορονικων εστερων και οξεων
AU2003238007A8 (en)	2003-12-22	Methods of treating alzheimer's disease using aryl alkanoic acid amides
MX2007004763A (es)	2007-09-27	Acidos carboxilicos (bifenilo) y derivados de los mismos.
EP1947942A4 (en)	2010-04-14	METHOD OF TREATING BONE BY MODULATION OF AN ARACHIDOIC ACID METABOLIC OR SIGNALING PATH
ATE406863T1 (de)	2008-09-15	Dentalzusammensetzungen und verfahren mit arylsulfinatsalzen
MY148953A (en)	2013-06-14	Substituted biphenyl carboxylic acids and derivatives thereof
ZA200708835B (en)	2009-09-30	Age inhibitors
SV2010003770A (es)	2011-05-20	Composicion y proceso- 356
ATE504580T1 (de)	2011-04-15	Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
JP2008510815A5 (ja)	2008-10-09	プラスミノゲン活性化因子阻害剤１型（ｐａｉ−１）調節剤としてのオキサゾロ−ナフチル酸
MY137277A (en)	2009-01-30	Pharmaceutically useful salts of carboxylic acid derivates
AU2003207467A8 (en)	2003-07-24	Crystallization of amino acids using ultrasonic agitation
ZA200803206B (en)	2009-08-26	Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
TNSN07228A1 (en)	2008-11-21	Manufacture process of organic compounds
MXPA05010398A (es)	2005-11-04	Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
UA94955C2 (en)	2011-06-25	Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
TNSN07229A1 (en)	2008-11-21	Manufacture process of n-substituted salicylamides
FR2868702B1 (fr)	2006-12-22	Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant
ITMI20042231A1 (it)	2005-02-19	Cefdinir sale d'ammonio in forma cristallina
DE60218485D1 (de)	2007-04-12	Auflösungshemmende mittel zur herstellung von gereinigten solen
MXPA05010800A (es)	2005-12-14	Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos.
EA200600230A1 (ru)	2006-06-30	Способ получения хирально чистого n-(транс-4-изопропилциклогексилкарбонил)-d-фенилаланина и его кристаллических модификаций
IL183529A0 (en)	2007-09-20	Tri(hydroxymethyl)methylamine salt or an ethanol amine salt of (2s)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid
BR0009783A (pt)	2002-01-08	Sais de ácido fosfórico de uma diamina aromática